You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海醫藥(601607.SH):擬發行餘額不超150億元的債務融資產品
格隆匯 03-30 01:14

格隆匯3月30日丨上海醫藥(601607.SH)公佈,為進一步拓寬公司融資渠道,優化公司債務結構,合理控制財務成本,同時使公司能夠靈活選擇融資工具,及時滿足資金需求,根據相關規定,公司擬發行餘額不超過等值人民幣150億元的各類短期債務融資產品和中長期債務融資產品,融資產品類別包括但不限於短期融資券、超短期融資券、短期公司債券、中期票據、中長期公司債券、永續債、類永續債、資產支持票據、綠色債務融資工具和其他短期及中長期債務融資產品。

公司發行債務融資產品募集的資金將用於補充公司及子公司營運資金,償還債務等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account